GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi India Ltd (NSE:SANOFI) » Definitions » Other Operating Expense

Sanofi India (NSE:SANOFI) Other Operating Expense : ₹7,923 Mil (TTM As of Dec. 2023)


View and export this data going back to 2003. Start your Free Trial

What is Sanofi India Other Operating Expense?

Sanofi India's Other Operating Expense for the three months ended in Dec. 2023 was ₹1,427 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₹7,923 Mil.

Sanofi India's quarterly Other Operating Expense declined from Jun. 2023 (₹2,214 Mil) to Sep. 2023 (₹2,165 Mil) and declined from Sep. 2023 (₹2,165 Mil) to Dec. 2023 (₹1,427 Mil).

Sanofi India's annual Other Operating Expense declined from Dec. 2021 (₹6,236 Mil) to Dec. 2022 (₹5,746 Mil) and declined from Dec. 2022 (₹5,746 Mil) to Dec. 2023 (₹5,410 Mil).


Sanofi India Other Operating Expense Historical Data

The historical data trend for Sanofi India's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi India Other Operating Expense Chart

Sanofi India Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,135.00 7,376.00 6,236.00 5,746.00 5,410.00

Sanofi India Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,336.00 2,117.00 2,214.00 2,165.00 1,427.00

Sanofi India Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹7,923 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sanofi India Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Sanofi India's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanofi India (NSE:SANOFI) Business Description

Traded in Other Exchanges
Address
Saki Vihar Road, Sanofi House, CTS Number 117-B, L&T Business Park, Powai, Mumbai, MH, IND, 400072
Sanofi India Ltd is a drug manufacturing company that focuses on a range of therapeutic areas, including Diabetes, Cardiology, Consumer Healthcare, Hospital, Central Nervous System, and Anti-Histamines. The company's diabetes presence includes oral anti-diabetic products and insulin. The consumer healthcare area also maintains a nutraceutical portfolio. The company's export markets include Germany, the U.K., Australia, and Russia. The company utilizes strategic partnerships as a component of its growth strategy.

Sanofi India (NSE:SANOFI) Headlines

No Headlines